Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ellen Bork"'
Autor:
Vahid Riahi, Hamed Hassanzadeh, Sankalp Khanna, Justin Boyle, Faraz Syed, Barbara Biki, Ellen Borkwood, Lianne Sweeney
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Operating rooms (ORs) are one of the costliest units in a hospital, therefore the cumulative consequences of any kind of inefficiency in OR management lead to a significant loss of revenue for the hospital, staff dissatisfaction,
Externí odkaz:
https://doaj.org/article/afee06b3291d461eaeec1e6cf4dac507
Autor:
Ellen Bork, Henning Lindeberg, Søren Schifter, Lis Johannsen, Jens Faber, Christopher B Bunker, Paul Brickell
Publikováno v:
Clinical Endocrinology. 39:59-65
Summary OBJECTIVE Calcitonin gene-related peptide (CGRP) is a regulatory peptide encoded by the calcitonin gene. CGRP is expressed in increased amounts by the cells of medullary thyroid carcinomas and has been demonstrated by immunohistochemistry to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13a7646789cd782c2707568412ab487b
https://doi.org/10.1111/j.1365-2265.1993.tb01751.x
https://doi.org/10.1111/j.1365-2265.1993.tb01751.x
Autor:
Ronald, Dworkin, Jonathan, Kay, Christopher M, Schnaubelt, Harold, Orlans, Sheldon, Rabinowitz, Arthur H, Bienenstock, Mary Ellen, Bork, Guenter, Lewy, Henry J, Hyde, Suzanne F, Singer, Marc, Gellman, Charles R, Ewy, Haven Bradford, Gow, Barton P, Jenks, Erlend, Olson, Frederic, Wile, Robert Greer, Cohn, Edward T, Oakes, Jean Bethke, Elshtain, James Q, Wilson
Publikováno v:
Commentary (New York, N.Y.). 97(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a557dd5df1ca923b055ac8c2d0b5026e
https://pubmed.ncbi.nlm.nih.gov/11659743
https://pubmed.ncbi.nlm.nih.gov/11659743
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 9(9)
A randomized study comparing teniposide (VM-26) and etoposide (VP-16) was performed to investigate whether there are any differences in the activity and toxicity of these two analogs in small-cell lung cancer (SCLC). Only previously untreated patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c54bfba0bf76c4d01edbc21b7b16da
https://pubmed.ncbi.nlm.nih.gov/1651994
https://pubmed.ncbi.nlm.nih.gov/1651994
Publikováno v:
Journal of Clinical Oncology. 24:8508-8508
8508 Background: Oral mucositis is a frequent complication to many chemotherapy agents in conventional doses. Chlorhexidine prophylaxis has been beneficial in some studies and suggested detrimental in others, but never compared to cryotherapy. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::184118f153cfae3dc18e092664555b79
https://doi.org/10.1200/jco.2006.24.18_suppl.8508
https://doi.org/10.1200/jco.2006.24.18_suppl.8508
Publikováno v:
European Journal of Cancer and Clinical Oncology. 23:1837-1843
TCNU (1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosour ea) is a newly developed water-soluble nitrosourea based on the endogenous aminoethanesulphonic acid taurine. TCNU was in an extended phase I trial given orally every 4-8 weeks u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::382e6b5c36955fe3eb2eee0dfd53d3bd
https://doi.org/10.1016/0277-5379(87)90049-6
https://doi.org/10.1016/0277-5379(87)90049-6
Autor:
Per Dombernowsky, Jens Benn Sørensen, Birgit Bodker, Kristian Aabo, Ellen Bork, Rollf Malmberg, Heine H. Hansen, Mogens Herman Hansen
Publikováno v:
Journal of Clinical Oncology. 5:1169-1177
Two hundred seventy-nine patients with previously untreated nonresectable adenocarcinoma of the lung (ACL) entered a prospective randomized trial, comparing vindesine (VDS) to a combination of lomustine (CCNU), cyclophosphamide (CTX), and methotrexat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed0a3cb556b59f502ee56ee771276e4
https://doi.org/10.1200/jco.1987.5.8.1169
https://doi.org/10.1200/jco.1987.5.8.1169
Publikováno v:
European Journal of Cancer and Clinical Oncology. 24:201-204
The quianazoline antifolate N 10 -propargyl-5,8-dideazafolic acid (ICI 155,387), an inhibitor of thymidylate synthetase (TS), was evaluated for clinical toxicity in a phase I trial. The compound was given once every week as a bolus injection. Fourtee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278ff328572c015fd903844c43923f82
https://doi.org/10.1016/0277-5379(88)90253-2
https://doi.org/10.1016/0277-5379(88)90253-2
Autor:
Jens J. Holst, Ellen Bork, Petter Urdal, Mogens Hansen, Frode Engbaek, Søren Schifter, Elisabeth Paus, Mogens Fenger
Publikováno v:
European journal of cancerclinical oncology. 24(6)
Creatine kinase (CK-BB), neuron specific enolase (NSE), ACTH, calcitonin, serotonin and gastrin releasing peptide (GRP) were measured in serum or plasma before and immediately after initiation of treatment in patients with small cell lung cancer (SCC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd29b58caebaea9553dbf7c79777126
https://pubmed.ncbi.nlm.nih.gov/2842159
https://pubmed.ncbi.nlm.nih.gov/2842159
Publikováno v:
European journal of cancerclinical oncology. 25(10)
Brequinar, DUP 785, is a substituted 4-quinoline carboxylic acid derivative which in preclinical studies has shown broad antitumor activity. It is a novel antimetabolite blocking pyrimidine nucleotide synthesis. In a clinical phase I study, 83 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f0c4250bf3940db6589e59636820645
https://pubmed.ncbi.nlm.nih.gov/2591433
https://pubmed.ncbi.nlm.nih.gov/2591433